NASDAQ:ALKS
Alkermes plc Stock News
$24.68
+0.240 (+0.98%)
At Close: Apr 26, 2024
Intercept (ICPT) Settles Litigation With Dr. Reddy's for Ocaliva
02:20pm, Thursday, 18'th Aug 2022 Zacks Investment Research
Intercept (ICPT) enters into a settlement agreement with Dr. Reddy's for lead drug Ocaliva's generic version.
GSK NDA for Myelofibrosis Candidate Gets FDA Acceptance
12:46pm, Thursday, 18'th Aug 2022 Zacks Investment Research
GSK's NDA for momelotinib for treating myelofibrosis was based on data from key phase III studies, including the pivotal MOMENTUM study.
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
12:40pm, Thursday, 18'th Aug 2022 Zacks Investment Research
AbbVie (ABBV) has several new drugs with the potential to drive revenues once Humira loses U.S. exclusivity in 2023. Its early and mid-stage pipeline has several candidates with blockbuster potential.
GSK NDA for Myelofibrosis Candidate Gets FDA Acceptance
09:47am, Thursday, 18'th Aug 2022
GSK's NDA for momelotinib for treating myelofibrosis was based on data from key phase III studies, including the pivotal MOMENTUM study.
LHC Group (LHCG) to Expand Access in Georgia With New Buyout
01:31pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
LHC Group (LHCG) is set to acquire Georgia-based Three Rivers Home Health that will expand its service footprint in 36 counties in the state of Georgia.
Merck (MRK) Enters Into Circular RNA Collaboration With Orna
12:47pm, Wednesday, 17'th Aug 2022 Zacks Investment Research
Merck (MRK) is set to make an upfront payment of $150 million to Orna for rights to the latter's circular RNA technology to make vaccines and therapeutics for infectious disease and oncology.
DENTSPLY SIRONA (XRAY) Falls After Nasdaq's Delinquency Notice
11:54am, Wednesday, 17'th Aug 2022 Zacks Investment Research
The Nasdaq exchange issues a notice to DENTSPLY SIRONA (XRAY) for filing delinquency from the exchange and for non-compliance with the Nasdaq Listing Rules. Shares fall.
Gilead (GILD) Announces Positive Data on Breast Cancer Drug
05:10pm, Tuesday, 16'th Aug 2022 Zacks Investment Research
Gilead (GILD) breast cancer drug Trodelvy improves overall survival in pre-treated HR+/HER2- metastatic breast cancer patients. The company will also acquire the remaining rights to the drug.
Novartis (NVS) NSCLC Study Fails to Meet Primary Endpoint
04:00pm, Tuesday, 16'th Aug 2022 Zacks Investment Research
Novartis (NVS) suffers a setback as canakinumab fails to meet the primary goal in yet another study for lung cancer.
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022
02:12pm, Tuesday, 16'th Aug 2022 Benzinga
Upgrades
Craig-Hallum upgraded the previous rating for CalAmp Corp (NASDAQ:CAMP) from Hold to Buy. In the first quarter, CalAmp showed an EPS of $0.10, compared to $0.08 from the year-ago quarter. At
AstraZeneca's (AZN) Lynparza sNDA Gets FDA Priority Tag
12:50pm, Tuesday, 16'th Aug 2022 Zacks Investment Research
FDA grants priority review to AstraZeneca (AZN) and Merck's (MRK) Lynparza as a combination therapy for patients with metastatic castration-resistant prostate cancer.
Are Medical Stocks Lagging Alkermes (ALKS) This Year?
01:40pm, Monday, 15'th Aug 2022 Zacks Investment Research
Here is how Alkermes (ALKS) and Elevance Health (ELV) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Alkermes (ALKS) This Year?
11:17am, Monday, 15'th Aug 2022
Here is how Alkermes (ALKS) and Elevance Health (ELV) have performed compared to their sector so far this year.
Here's Why You Should Buy Patterson Companies (PDCO) Stock
02:33pm, Friday, 12'th Aug 2022 Zacks Investment Research
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
Roche (RHHBY) Influenza Drug Gets FDA Nod for Children
02:33pm, Friday, 12'th Aug 2022 Zacks Investment Research
Roche (RHHBY) obtains FDA approval for expanded indication of influenza drug Xofluza.
